Trial Profile
Effect of bendamustine in patients with lymphoproliferative malignancies
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 May 2015
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary) ; Rituximab
- Indications Chronic lymphocytic leukaemia; Lymphoproliferative disorders; Multiple myeloma; Non-Hodgkin's lymphoma
- Focus Adverse reactions
- 04 May 2015 New trial record